Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

HERE Launches Fourth-Generation WAKUKU Series Globally, Expanding Its Imaginative IP Universe

June 9, 2026

Oukitel WP500 Ultra Makes a Global Leap in Mobile Technology: The World’s First AI Thermal Imaging Rugged Phone with Privacy Kill Switch

June 9, 2026

Kelley Drye Strengthens Delaware Statutory Trust Practice with Addition of Tax Partner Ed Hannon

June 9, 2026

City of Vancouver sets date for free English Bay fireworks show

June 9, 2026

Liberals open to shorter metadata rules but splitting bill ‘not an option’

June 9, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Companion Animal Health Market Forecast 2026-2033 Featuring Strategic Analysis of Agrolabo, Boehringer Ingelheim, Ceva, Elanco, IDEXX Labs and More
Press Release

Companion Animal Health Market Forecast 2026-2033 Featuring Strategic Analysis of Agrolabo, Boehringer Ingelheim, Ceva, Elanco, IDEXX Labs and More

By News RoomMarch 30, 20263 Mins Read
Companion Animal Health Market Forecast 2026-2033 Featuring Strategic Analysis of Agrolabo, Boehringer Ingelheim, Ceva, Elanco, IDEXX Labs and More
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, March 30, 2026 (GLOBE NEWSWIRE) — The “Companion Animal Health Market Size, Share & Trends Analysis Report by Animal, Product, Distribution Channel, End-use, Region, and Segment Forecasts, 2026-2033” has been added to ResearchAndMarkets.com’s offering.

The global companion animal health market, initially valued at USD 25.46 billion in 2025, is on a trajectory to soar to USD 56.41 billion by 2033, driven by a robust CAGR of 10.6% from 2026 to 2033. Key growth factors include rapid advancements in companion animal health, increased zoonotic disease transfers from pets, regulatory changes, and enhanced R&D and procedural innovations.

Innovation in therapeutics, diagnostics, and care delivery is aligning the companion animal health industry with the complex and valuable nature of human healthcare. Advancements in molecular biology, biologics, and formulation science are enabling targeted therapies, supporting disease management long-term. Regulatory frameworks are adapting, with actions like the FDA’s inclusion of Faunamor for minor species in April 2025 highlight the growing acceptance of precision-driven veterinary medicines. The adoption of AI in diagnostics and regenerative medicine is enhancing clinical outcomes and operational efficiency.

Heightened awareness of zoonotic diseases shared by pets and humans is propelling market demand for preventive veterinary interventions. With pets part of everyday lives, associated risks like bacterial infections and vector-borne diseases have emerged as public health concerns. Agencies such as the CDC emphasize preventive care, including vaccinations and parasite control, which now form part of standard pet ownership practices. These practices are prompting year-round prevention efforts, contributing to the frequent need for pharmaceuticals, diagnostics, and vaccines.

Regulatory frameworks are evolving, pivotal to companion animal health market expansion. By improving product approval processes, international cooperation, and modernizing laws, growth is gaining momentum. The U.S. FDA’s CVM, in December 2025, made progress by approving new drugs for conditions like congestive heart failure and antiseptic formulations, demonstrating the regulatory support for significant therapies. Industry groups, including the AVMA, call for updates to regulatory processes to accommodate complexity and innovative paces.

Report Scope

This comprehensive report projects revenue growth at global, regional, and country levels, analyzing industry trends across segments from 2021 to 2033. It segments the market based on animals, products, distribution channels, end use, and regions.

  • Animal Outlook (USD Million, 2021-2033): Dogs, Equine, Cats, Others
  • Product Outlook (USD Million, 2021-2033): Vaccines, Pharmaceuticals, Feed Additives, Diagnostics, Others
  • Distribution Channel Outlook (USD Million, 2021-2033): Retail, E-commerce, Hospital Pharmacies
  • End Use Outlook (USD Million, 2021-2033): Point-of-care/In-house testing, Hospitals & Clinics, Others
  • Regional Outlook (USD Million, 2021-2033): North America, Europe, Asia Pacific, Latin America, Middle East & Africa
  • Comprehensive Market Analysis: Detailed insights into regional and segmental market dynamics.
  • Competitive Landscape: Insights into key players’ market presence.
  • Future Trends: Identifying trends and drivers shaping the market’s future.
  • Actionable Recommendations: Strategies for uncovering new revenue channels and informing business decisions.

Key Attributes

Report Attribute Details
No. of Pages 150
Forecast Period 2025-2033
Estimated Market Value (USD) in 2025 $25.46 Billion
Forecasted Market Value (USD) by 2033 $56.41 Billion
Compound Annual Growth Rate 10.6%
Regions Covered Global

The leading players profiled in this Companion Animal Health market report include:

  • Agrolabo S.p.A.
  • Boehringer Ingelheim International GmbH
  • Ceva
  • Elanco
  • IDEXX Laboratories, Inc.
  • Indian Immunologicals Ltd.
  • Merck & Co., Inc.
  • Norbrook
  • Vetoquinol
  • Virbac
  • Zoetis Services LLC

For more information about this report visit https://www.researchandmarkets.com/r/czz9tp

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Companion Animal Health Market

            
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

HERE Launches Fourth-Generation WAKUKU Series Globally, Expanding Its Imaginative IP Universe

Oukitel WP500 Ultra Makes a Global Leap in Mobile Technology: The World’s First AI Thermal Imaging Rugged Phone with Privacy Kill Switch

Kelley Drye Strengthens Delaware Statutory Trust Practice with Addition of Tax Partner Ed Hannon

Event-Ready Commerce, Powered by Fello + Toast

VISIT FLORIDA Highlights St. Augustine as City that Shaped U.S. History

Comet Launches Cost Intelligence in Opik — the First Tool to Give Engineering Leaders Complete Visibility Into Claude Code and Codex Spend

Palmetto Publishing Releases Tyrel Ackman’s Young Adult Dystopian Novel Power: Blackout

Rick Castiglia Joins DCS as General Counsel, Chief Ethics Officer, and Corporate Secretary

Chemiluminescence Immunoassay Market by Product, Technology, Sample Type, Application, End User – Global Forecast to 2031

Editors Picks

Oukitel WP500 Ultra Makes a Global Leap in Mobile Technology: The World’s First AI Thermal Imaging Rugged Phone with Privacy Kill Switch

June 9, 2026

Kelley Drye Strengthens Delaware Statutory Trust Practice with Addition of Tax Partner Ed Hannon

June 9, 2026

City of Vancouver sets date for free English Bay fireworks show

June 9, 2026

Liberals open to shorter metadata rules but splitting bill ‘not an option’

June 9, 2026

Latest News

Event-Ready Commerce, Powered by Fello + Toast

June 9, 2026

The App Store is going to add subscription bundles soon

June 9, 2026

VISIT FLORIDA Highlights St. Augustine as City that Shaped U.S. History

June 9, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version